510(k) device
NOxBOXi Nitric Oxide Delivery System
Linde Gas & Equipment, Inc. · Apparatus, Nitric Oxide Delivery (MRN, Class II) · First FDA decision Apr 27, 2022, newest May 23, 2024Respiratory failure and ventilation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
0
Naming "NOxBOXi"
MAUDE reports
144
Brand "NOxBOXi", since 2015
PubMed studies
2
Mentioning "NOxBOXi"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NOxBOXi Nitric Oxide Delivery System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K233251 · Decided May 23, 2024 · 238 days after receipt
Device type: Apparatus, Nitric Oxide Delivery (MRN) · Anesthesiology & Respiratory
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NOxBOXi", any status and sponsor, newest update first.
No registered device study names "NOxBOXi".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NOxBOXi", and for the whole product code for context.
This brand
144 reports: 104 malfunction, 35 injury, 5 death
Whole product code MRN
1,689 reports: 1,573 malfunction, 91 injury, 15 death
Newest reports for this brand
- NOxBOXi Nitric Oxide delivery systemMalfunction
3012796317-2026-00058 · Received Oct 22, 2026 · Event dated Aug 9, 2026
Device type: Apparatus, Nitric Oxide Delivery (MRN)
Device problem as coded: Inappropriate or Unexpected Reset; Application Program Freezes or Fails to Launch
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- NOxBOXi Nitric Oxide Delivery System. Model Number: NOXBOX-I.Open, Classified
Z-3306-2026 · Started Sep 14, 2026 · Posted by FDA Sep 25, 2026
Reason given: Potential for irregular oxygen readings due to a manufacturing issue affecting certain oxygen sensors.
Cause as FDA categorized it: Component design/selection · Device type: Apparatus, Nitric Oxide Delivery (MRN)
3 more recall records with a free account
Published research
The most relevant PubMed records for "NOxBOXi"[tiab]. The summary above synthesizes these.
- Circuit-Directed Nitric Oxide in Anticoagulation-Contraindicated Adult Extracorporeal Membrane Oxygenation: A Single-Center Case Series.
Kadir S, Jain S, Madbak F, et al. · ASAIO J · 2026
- NOxBOXi fluctuations delivering inhaled nitric oxide via high-frequency oscillator: A conundrum and a hypothesis.
Singh AP, Chao H, Nguyen R, et al. · Pediatr Pulmonol · 2024Letter
Other devices of this type
Also filed under product code MRN.
- Inomax Ds (Delivery System)Ino Therapeutics · 510(k) 2012
- ULSPIRA TS Nitric Oxide Therapy SystemAirgas Therapeutics, LLC · 510(k) 2026
- EVOLVE Nitric Oxide Delivery SystemMallinckrodt Manufacturing, LLC · 510(k) 2025
- Inomax Dsir (Delivery System)Ino Therapeutics · 510(k) 2013
- EVOLVE Nitric Oxide Delivery SystemMalinckrodt Manufacturing, LLC · 510(k) 2024
- Inomax DSIRMallinckrodt Manufacturing, LLC · 510(k) 2023
- The NOxBOXi Nitric Oxide Delivery SystemPraxair, Inc. · 510(k) 2020
- INOmax DSIR PlusMallinckrodt Manufacturing, LLC · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.